Mercury Pharmaceuticals

15

Jun 2026

Research links low-energy falls to triage undertreatment in female brain injuries

Female patients with traumatic brain injury (TBI) are 26% less likely to be admitted to a specialized trauma center than males, according to a study on data from Ontario published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251721. This difference persisted even after the researchers accounted for factors such as age, severity of injury, other health conditions, and socioeconomic circumstances.

READ MORE

15

Jun 2026

Constant digital tracking of young adults backfires, fueling parental anxiety

Built-in smartphone apps and location sharing features allow parents to see where their children are at any moment: Did they arrive safely? Are they where they said they'd be? How far away are they if there's an emergency?

READ MORE

15

Jun 2026

Australia’s diphtheria outbreak shows why boosters, antibiotics, and better housing all matter

A 131-case diphtheria outbreak in Australia’s Northern Territory showed how toxigenic Corynebacterium diphtheriae can re-emerge even in highly vaccinated populations. Genomic and epidemiological evidence linked most cases to a dominant ST381 strain, with transmission shaped by overcrowding, poor skin health, and persistent health inequities.

READ MORE

15

Jun 2026

Researchers map rare DHDDS disease mechanism using lab-grown mini brains

Variants in the DHDDS gene cause a severe neurodegenerative condition, characterized by tremors, seizures, coordination and learning difficulties, usually manifesting in early childhood. This Parkinson's-like condition is extremely rare, and until recently, parents were told that there was nothing that could be done to slow down its progression.

READ MORE

15

Jun 2026

Lab trials prove copper therapy enhances cognitive function and spatial learning

Monash University researchers have found in laboratory experiments that a drug which delivers copper to the brain significantly reduces toxic Alzheimer's proteins and improves long-term spatial memory.

READ MORE

15

Jun 2026

AI could help food systems detect pathogens, fraud, and contamination faster

A systematic review of 161 peer-reviewed publications found that AI research in food safety has expanded rapidly, rising from one study in 2012 to 46 in 2023. The review shows that machine learning and deep learning are being studied for pathogen detection, chemical contamination prediction, food fraud screening, outbreak surveillance, and regulatory decision-making, but data gaps, class imbalance, privacy limits, and model interpretability remain major barriers.

READ MORE

14

Jun 2026

Digital brain twin recreates brain activity in a toddler with autism

Researchers developed FEDE, a high-fidelity digital brain twin pipeline that combines MRI-derived anatomy with biophysical modeling to reconstruct brain structure and simulate EEG activity. In a single toddler with autism spectrum disorder, the model closely reproduced recorded brain activity and suggested possible patient-specific alterations in neural noise and excitatory-inhibitory balance.

READ MORE

14

Jun 2026

New poll reveals how politics reshaped trust in U.S. public health

A Harvard Chan/de Beaumont national poll of 2,205 U.S. adults found CDC trust dropped to 50% one year into new federal public health leadership, while state and local health agencies remained more trusted.

READ MORE

14

Jun 2026

Glucosamine may worsen Alzheimer’s by fueling abnormal brain glycosylation

A Nature Metabolism study identifies brain hyperglycosylation as a metabolic driver of Alzheimer’s disease, with increased N-glycan biosynthesis seen in human AD tissue and mouse models. Reducing glycosylation improved memory in AD mice, while glucosamine worsened memory deficits in 5xFAD mice and was associated with poorer outcomes in dementia patients.

READ MORE

14

Jun 2026

Short-chain oat fiber helps steady glucose and ease gut symptoms in pilot trial

A 14-day open-label pilot study in 63 healthy adults found that short-chain oat fiber was well tolerated at doses up to 20 g/day and was associated with improved gastrointestinal symptom scores.

READ MORE